XML 42 R28.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments (Details Narrative) - USD ($)
 12 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2016
Weighted average exercise price $ 2.87    
Remaining stock based compensation $ 6,827,054    
Number of warrants exercised 678,379    
Share based compensation $ 5,517,004 $ 4,135,570 $ 5,062,267
Share based compensation with the vesting of restricted stock   0 610,000
General and administrative [Member]      
Share based compensation 2,699,557 2,017,199 3,208,220
Rent expense $ 151,405 $ 127,993 $ 125,317
Number of options granted to consultants 350,000    
Number of options converted to warrants 350,000    
Purchase Warrants [Member]      
Number of warrant exercisable 678,379    
Weighted average exercise price $ 3.00    
Expiration date Jul. 05, 2018    
Number of warrants exercised   200,000 2,421,894
Number of common shares called   52,562 1,979,246
Number of shares issued for cash     41,687
Number of share purchase warrants exercised $ 737,393    
Exercised price (in dollars per share) $ 3.00    
Number of share purchase warrants exercised $ 18,750    
Exercised price (in dollars per share) $ 1.24    
Number of common stock to be issued 125,748    
Number of additional common stock to be issued 80,981    
2015 Omnibus Incentive Plan [Member]      
Maximum number of common shares reserved for future issuance 6,050,553    
Description of grant option The exercise price will be determined by the board of directors at the time of grant shall be at least equal to the fair market value on such date. If the grantee is a 10% stockholder on the grant date, then the exercise price shall not be less than 110% of fair market value of the Company’s shares of common stock on the grant date.    
Expiration period 10 years